Patrick Donnelly

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

July 31, 2018
ProPharma Group Announces New Medical Information Contact Center
ProPharma Group today announces the opening of a new medical information contact center in… Read More
July 16, 2018
ProPharma Group Announces Acquisition of Xendo
ProPharma Group announces the acquisition of Xendo Holding B.V. (“Xendo”), a Netherlands-based provider of… Read More
July 10, 2018
Implementing a Risk-Based Supplier Management Program
What steps should manufacturers take to detect and control supplier issues before commencing the… Read More
More Articles

UPCOMING Events

August 23, 2018
ISPE Midwest Golf Tournament & Dinner
Join us at the ISPE Midwest Chapter’s Annual Golf Tournament and Dinner! This event is always a great af... Read More
September 24, 2018
PDA/FDA Joint Regulatory Conference
In keeping with the focus on putting patients first, this Conference will explore topics that ensure innovatio... Read More
September 26, 2018
ISPE Boston Product Show
Visit the ProPharma Group team during the ISPE Boston Product Show! At this annual event, you’ll see the mos... Read More
All Events
Contact Us